![David P. Nowotnik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David P. Nowotnik
Directeur/Bestuurslid bij TheraTarget, Inc.
Actieve functies van David P. Nowotnik
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TheraTarget, Inc.
![]() TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Directeur/Bestuurslid | - | - |
Loopbaan van David P. Nowotnik
Eerdere bekende functies van David P. Nowotnik
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Corporate Officer/Principal | 01-01-1994 | 01-01-1998 |
ABEONA THERAPEUTICS INC. | Corporate Officer/Principal | 01-11-1998 | - |
Opleiding van David P. Nowotnik
University of London | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
TheraTarget, Inc.
![]() TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Health Technology |
- Beurs
- Insiders
- David P. Nowotnik
- Ervaring